Breaking the Barrier: Redefining Women’s Health for Better Clinical Trial Outcomes

The current definition of women’s health may not fully capture the potential impacts on clinical trial outcomes, warranting a discussion. In our series on women’s health, we explore how broadening the definition can open up funding to address this critical issue.

Our second episode features expert guests including Sans Thakur, Founder and Chairwoman of Tower Capital; Chia Chia Sun, Chief Commercial Officer at Fab Biopharma; Elisa Cascade, Chief Product Officer at Advarra; Shawana Moore, Medical Advisor on the Advisory Council for Healthy Women; and Katie Schubert, President and Chief Executive Officer of the Society for Women’s Health.

Lori Ellis, Head of Insights at BioSpace hosts the episode. Listeners can tune in to the podcast on Spotify, Apple Podcasts, Amazon Music, and iHeart Radio for an in-depth discussion on redefining women’s health and its potential benefits for future generations.